Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China
· Delayed Price · Currency is CNY 23.63
-0.37 (-1.54%)
At close: Jun 5, 2025, 2:57 PM CST
SHA:688217 Market Cap
SHA:688217 has a market cap or net worth of 1.32 billion as of June 13, 2025. Its market cap has decreased by -4.86% in one year.
Market Cap
1.32B
Enterprise Value
1.11B
Revenue
232.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.63
Market Cap Chart
Since May 17, 2021, SHA:688217's market cap has decreased from 5.91B to 1.32B, a decrease of -77.66%. That is a compound annual growth rate of -30.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 1.37B | 34.71% |
| Dec 31, 2024 | 1.02B | -49.08% |
| Dec 29, 2023 | 2.00B | 1.72% |
| Dec 30, 2022 | 1.96B | -51.39% |
| Dec 31, 2021 | 4.04B | -31.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 369.84B |
| Shenzhen Mindray Bio-Medical Electronics | 286.14B |
| WuXi AppTec | 195.03B |
| Sichuan Biokin Pharmaceutical | 135.34B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.36B |
| Aier Eye Hospital Group | 114.89B |
| Shanghai United Imaging Healthcare | 108.35B |
| Yunnan Baiyao Group Co.,Ltd | 101.72B |